CHICAGO—Men on anticoagulation therapy (AAT) can safely undergo penile prosthesis implantation, according to findings presented at the World Meeting on Sexual Medicine.
Nelson Bennett, Jr., MD, and Kai Hammerich, MD, of the Lahey Clinic Medical Center in Burlington, Mass., reported on a study of 91 men undergoing implantation of inflatable penile prostheses (IPP). Of these men, 11 patients continued AAT during surgery. Drs. Bennett and Hammerich found no significant differences in length of hospital stay between men who were on AAT and those who were not (3.2 vs. 1.1 days). Men on AAT also did not differ significantly from those not on AAT with respect to estimated blood loss (127.27 vs. 124.50 mL) and operative time (155.9 vs. 168 min). The researchers observed no bleeding complications, and no patient required a transfusion.
“IPP implantation may be safely completed in the setting of AAT without increased blood loss, hospital stay, or complication rate,” the investigators concluded. “Furthermore, this patient group might benefit from continuation of anticoagulation for pre-existing disease.”
The meeting is cosponsored by the International Society for Sexual Medicine and the Sexual Medicine Society of North America.